IMPAVIDO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69051-300 -
Package NDC
69051-300-01 -
Application number
NDA204684 -
SPL ID
5d5727be-1d76-8f8f-e063-6294a90aa8be -
SPL set ID
bcb387ac-2e90-4f5e-94b2-d3635190678e -
UNII
53EY29W7EC -
RxCUI
1494071 -
RxCUI
1495070
What the source publishes
- Labeler
- Profounda, Inc.
- Active ingredients
- miltefosine
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "IMPAVIDO",
"splId": "5d5727be-1d76-8f8f-e063-6294a90aa8be",
"labels": [
{
"setId": "bcb387ac-2e90-4f5e-94b2-d3635190678e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcb387ac-2e90-4f5e-94b2-d3635190678e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bcb387ac-2e90-4f5e-94b2-d3635190678e"
}
],
"routes": [
"ORAL"
],
"labeler": "Profounda, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (69051-300-01) / 14 CAPSULE in 1 BLISTER PACK",
"package_ndc": "69051-300-01",
"identifierStatus": "well-formed",
"marketing_end_date": "20280131",
"marketing_start_date": "20151029"
}
],
"productId": "69051-300_5d5727be-1d76-8f8f-e063-6294a90aa8be",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "69051-300",
"deaSchedule": null,
"genericName": "miltefosine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20280131",
"activeIngredients": [
{
"name": "MILTEFOSINE",
"strength": "50 mg/1"
}
],
"applicationNumber": "NDA204684",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20151029",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000190851"
],
"unii": [
"53EY29W7EC"
],
"rxcui": [
"1494071",
"1495070"
],
"spl_set_id": [
"bcb387ac-2e90-4f5e-94b2-d3635190678e"
],
"pharm_class_epc": [
"Antileishmanial [EPC]"
],
"manufacturer_name": [
"Profounda, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69051-300_5d5727be-1d76-8f8f-e063-6294a90aa8be"